Compound, N-butyl-deoxynojirimycin-6-phosphate
US5103008A · kind A · utility
35Cited by
4References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 1991 |
| Grant date | Apr 7, 1992 |
| Priority date | — |
| Expiry date | Apr 12, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/59
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A method is provided for converting therapeutic glycosidase inhibitors to novel prodrugs by phosphorylation of a free hydroxyl group on the molecule to substantially reduce the glycosidase inhibitory activity without thereby substantially reducing the therapeutic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.